[SyneuRx] Important resolutions of the 115 Annual General Meeting
NQ Score
42/100
N1 Content Completeness
10
AI Summary (NQ-processed)
SyneuRx held its Annual General Meeting on May 29, 115. The meeting approved the 114 fiscal year loss compensation plan and financial statements, and passed amendments to the Articles of Incorporation and the 'Procedures for Acquisition or Disposal of Assets'.
AI Analysis
Frequently Asked Questions
- Q: What was passed at the SyneuRx shareholder meeting?
- A: Amendments to the Articles of Incorporation and asset acquisition/disposal procedures were passed.